Tanzania's Medikea Raises $1.2M Pre-Seed to Expand Clinic Network

Medikea Co-founders: Elvis Silayo, Munir Issa, and Desire Ruhinda

Tanzanian health-tech entity Medikea has secured US$1.2 million in pre-seed funding to expand its asset-heavy, vertically integrated clinical network from four to ten facilities.

Backed by Baobab Network, Catalyst Fund, and develoPPP Ventures, the capital injection aims to scale a model combining virtual consultations with owned physical clinics, diagnostic labs, and pharmacies.

Why Has Medikea Raised US$1.2 Million in Pre-Seed Funding?

Tanzanian healthcare startup Medikea has raised US$1.2 million in pre-seed funding to expand its clinic network, develop its technology platform and introduce additional specialist services across Tanzania.

Founded in 2022, Medikea operates an integrated healthcare model combining 24/7 virtual consultations with physical clinics, pharmacies and diagnostic laboratories. Unlike digital health platforms that rely primarily on existing healthcare providers, the company owns and operates its facilities, employs a salaried clinical team and develops its technology in-house.

The funding was raised through successive closes and attracted investors including Baobab Network, Catalyst Fund, and develoPPP Ventures. Additional backers include Madica, Impacc, Hustle Fund, O'Shaughnessy Ventures, Madiro, the Boehringer Ingelheim Foundation and an angel investor.

The investment comes as Medikea expands its physical presence beyond its existing locations. Following the opening of clinics in Arusha and Morogoro, the company now operates four facilities and plans to reach 10 within the next 12 months.

The new capital will support this expansion while strengthening the technology and clinical services underpinning its integrated healthcare model.

How Does Medikea's Integrated Healthcare Model Work?

Medikea combines virtual consultations, physical clinics, diagnostic laboratories and pharmacies within a single care delivery system. The model is designed to help patients access different stages of outpatient treatment without navigating multiple disconnected providers.

Its approach allows patients to:

• Access virtual consultations: Connect with healthcare professionals online 24 hours a day, seven days a week.
• Receive in-person treatment: Visit a Medikea clinic when a physical examination or face-to-face consultation is necessary.
• Access diagnostics: Use the company's diagnostic services to support assessment and treatment.
• Fill prescriptions: Obtain prescribed medication through Medikea pharmacies.
• Continue follow-up care: Access remote consultations and maintain a consistent medical record across the care journey.

The company also offers specialist services in paediatrics, women's health, dermatology, fertility and chronic disease management.

By owning the facilities involved in these services and employing its clinical team, Medikea aims to coordinate care more closely than a digital-only model. Its in-house technology is intended to connect consultations, diagnostics, prescriptions and follow-up appointments within one system.

The company focuses on outpatient care and refers patients to partner hospitals for surgery and advanced procedures.

Who Invested in Medikea's US$1.2 Million Funding Round?

Medikea's US$1.2 million pre-seed round was raised through successive closes, bringing together investors focused on early-stage businesses, healthcare and impact-driven ventures.

Investor	Role in the funding
Baobab Network	Early-stage investor
Catalyst Fund	Impact-focused investor
develoPPP Ventures	Participating investor
Madica	Participating investor
Impacc	Participating investor
Hustle Fund	Participating investor
O'Shaughnessy Ventures	Participating investor
Madiro	Participating investor
Boehringer Ingelheim Foundation	Participating investor
Angel investor	Additional backer

The funding supports Medikea's strategy of building healthcare delivery infrastructure alongside its digital platform.

Dr Elvis Silayo, co-founder and CEO of Medikea, said the company chose to rebuild the parts of the healthcare system on which its services depend rather than simply adding technology to existing processes.

His approach reflects the company's emphasis on operational control. By managing clinics, laboratories, pharmacies and its technology in-house, Medikea aims to improve the patient experience, offer more affordable care and maintain sustainable margins as it grows.

How Will Medikea Use Its New Funding to Expand in Tanzania?

Medikea plans to use the US$1.2 million investment to increase its geographic reach, improve its technology and broaden its clinical offering.

Its expansion strategy centres on three priorities:

1. Grow the clinic network

The company has opened new facilities in Arusha and Morogoro, bringing its total network to four clinics. It plans to add six more over the next 12 months, targeting a total of 10 facilities by the end of the following year, according to the announcement.

2. Develop technology and specialist services

Medikea intends to invest in its in-house technology platform and introduce additional specialist services. These investments are expected to support coordination between virtual consultations, physical examinations, diagnostics, pharmacy services and ongoing care.

3. Increase patient access

The startup aims to serve more than 100,000 patients over the next year. Reaching this target will require it to expand its clinical capacity while maintaining service quality across its physical and digital channels.

Growth metric	Current position or target
Founded	2022
Funding raised	US$1.2 million
Current clinic network	Four facilities
Target clinic network	10 facilities
Planned network expansion	Six additional facilities
Patient target	More than 100,000 over the next year
Geographic focus	Tanzania, with regional expansion planned

The clinic expansion represents a substantial increase from Medikea's current four-facility network. Its ability to reach 10 facilities will depend on execution across site expansion, staffing, logistics and service delivery.

Beyond Tanzania, the company plans to explore regional expansion as its operating model develops.

How Does Medikea Generate Revenue From Healthcare Services?

Medikea's vertically integrated model is designed to generate revenue across multiple stages of outpatient care rather than relying solely on consultation fees.

The company operates clinics, diagnostic laboratories and pharmacies, allowing it to participate in different parts of the patient journey. It also offers virtual consultations that can connect patients to in-person services when required.

According to Silayo, this structure creates a potential path to profitability by allowing the company to capture value across a broader range of services while maintaining control over delivery costs.

Medikea serves both patients who pay out of pocket and insured members. Its insurance and healthcare partners include:

• National Health Insurance Fund (NHIF)
• Jubilee Insurance
• Assemble Insurance
• GA Insurance

These relationships give the company channels through which to serve insured patients alongside individuals paying directly for care.

However, the company has not disclosed revenue, patient acquisition costs, clinic-level profitability or average spending per patient in the supplied announcement. Its ability to achieve sustainable margins will depend on factors such as clinic utilisation, staffing costs, diagnostic volumes, pharmacy sales and reimbursement arrangements.

Why Is Medikea's Healthcare Model Relevant to Tanzania?

Medikea is developing its services in Tanzania, where its integrated model aims to bring virtual and in-person healthcare into a coordinated system.

The company argues that building and operating its own facilities gives it greater control over service delivery than a model that relies exclusively on external providers. This approach can help coordinate the different stages of outpatient treatment, although its effectiveness and affordability will need to be assessed as the network expands.

Its focus on outpatient services also defines the limits of its model: patients requiring surgery or advanced procedures are referred to partner hospitals.

Maxime Bayen, partner at Catalyst Fund, said Medikea's combination of clinics, diagnostics, pharmacy services and virtual care could provide a scalable model for communities facing growing climate-related health risks.

That perspective connects the investment to healthcare resilience as well as access. Climate-related risks can increase demand for reliable healthcare services, making local service capacity and continuity of care important considerations. The supplied announcement, however, does not quantify Medikea's climate-related health impact or provide a specific estimate of the population it serves in climate-vulnerable areas.

What Does Medikea's Funding Mean for the Future of E-Health in Tanzania?

Medikea's US$1.2 million pre-seed round will help finance its transition from a four-facility healthcare network towards a target of 10 clinics, while supporting technology development and specialist services.

Its approach combines digital access with direct ownership of physical healthcare infrastructure. This differentiates the company from virtual-care platforms that primarily connect patients to third-party providers.

Three factors will shape its next phase of growth: expanding its clinic network, increasing patient numbers and demonstrating that its integrated operating model can deliver sustainable margins.

The target of more than 100,000 patients over the next year provides a measurable milestone, while the planned addition of six clinics will test the company's ability to scale its physical operations.

With backing from Baobab Network, Catalyst Fund, develoPPP Ventures and other investors, Medikea has secured capital to pursue its expansion strategy. Its progress will help show whether combining virtual consultations, clinics, diagnostics and pharmacy services can support a scalable healthcare business in Tanzania and, eventually, other regional markets.